N-(3-imidazol-1-ylpropyl)-3-phenyl-2-(4-piperazin-1-ylpiperidin-1-yl)quinoxaline-6-carboxamide
C30H36N8O — CID 118463654
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(3-imidazol-1-ylpropyl)-3-phenyl-2-(4-piperazin-1-ylpiperidin-1-yl)quinoxaline-6-carboxamide
N-(3-imidazol-1-ylpropyl)-3-phenyl-2-(4-piperazin-1-ylpiperidin-1-yl)quinoxaline-6-carboxamide (PubChem CID 118463654) has the molecular formula C30H36N8O and a molecular weight of 524.67 g/mol. Its IUPAC name is N-(3-imidazol-1-ylpropyl)-3-phenyl-2-(4-piperazin-1-ylpiperidin-1-yl)quinoxaline-6-carboxamide.
Molecular Properties
| Compound Name | N-(3-imidazol-1-ylpropyl)-3-phenyl-2-(4-piperazin-1-ylpiperidin-1-yl)quinoxaline-6-carboxamide |
|---|---|
| PubChem CID | 118463654 |
| Molecular Formula | C30H36N8O |
| Molecular Weight | 524.67 g/mol |
| Exact Mass | 524.30 |
| IUPAC Name | N-(3-imidazol-1-ylpropyl)-3-phenyl-2-(4-piperazin-1-ylpiperidin-1-yl)quinoxaline-6-carboxamide |
| SMILES | O=C(NCCCn1ccnc1)c1ccc2nc(N3CCC(N4CCNCC4)CC3)c(-c3ccccc3)nc2c1 |
| InChI | InChI=1S/C30H36N8O/c39-30(33-11-4-15-36-18-12-32-22-36)24-7-8-26-27(21-24)34-28(23-5-2-1-3-6-23)29(35-26)38-16-9-25(10-17-38)37-19-13-31-14-20-37/h1-3,5-8,12,18,21-22,25,31H,4,9-11,13-17,19-20H2,(H,33,39) |
| InChIKey | FJLXEMCEIFEXGJ-UHFFFAOYSA-N |
| XLogP | 3.19 |
| TPSA | 91.21 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 524.67 |
| LogP ≤ 5 | 3.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118463654 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.